Skip to content

Effect of food containing algae intake on metabolic syndrome related factor

Effect of food containing algae intake on metabolic syndrome related factor : A randomized double-blind placebo-controlled study - Effect of food containing algae intake on metabolic syndrome related factor

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043114
Enrollment
40
Registered
2022-01-24
Start date
2021-01-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults

Interventions

Intake test food thrice daily for 12 weeks. Intake control food thrice daily for 12 weeks.

Sponsors

Medical Corporation Hokubukai Utsukushigaoka hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Healthy Japanese women and men, between 20 and 64 years age when consent acquisition. 2)Body mass index of 24 to 30kg/m2 3)Waist circumference condition (>=85cm Male, >=90cm female) 4) Subjects who are no planned to change their lifestyle. 5) Individuals who don't have irregular or disturbed life style such as night shifts. 6)Subjects who have received enough explanation about this study and were able to understand that, then giving written informed consent.

Exclusion criteria

Exclusion criteria: 1)At least one previous medical history of malignant tumor, heart failure or myocardial infraction 2) Currently under the treatment for either cardiac arrhythmia, hepatic disorder, renal disorder, cerebrovascular disorder, rheumatism, diabetes mellitus. 3) Subjects who have previous and/or current medical history of serious disease (e.g., heart, liver, kidney, digestive organ). 4)Subjects who excessive alcohol intake. 5)Subjects who are allergic to medicines and/or the test food related products. 6)Subjects who took part in another clinical study within 3 months prior to the start of the present study. 7)Subjects who routinely intake supplements such as euglena, chlorella, spirulina, beta-glucan and supplement that may decrease the visceral fat level, cholesterol and blood sugar level. 8) Subjects are taking warfarin and the investigator has determined that it is inappropriate for this study. 9)Females who are pregnant or lactating, and females who could become pregnant or lactating during test period. 10)Subjects with abnormal food habit or irregular life style such as shifts workers or late-night workers. 11) Subjects who suffer from severe anemia 12)Subjects having blood sample 400mL or more taken within 3 months prior to the start of the present study (e.g. donated blood). 13)Subjects have some designed infectious disease. 14) Subjects deemed unsuitable by the investigator.

Design outcomes

Primary

MeasureTime frame
Visceral fat area, body fat percentage, HDL-cholesterol, triglyceride, fasting blood sugar, waist circumference, systolic blood pressure, diastolic blood pressure, LDL-cholesterol

Secondary

MeasureTime frame
1)Subcutaneous fat area, total fat area, weight 2)adiponectin, leptin, free fatty acids, Insulin, HOMA-R, HbA1c, Total cholesterol 3)Immunoglobulin, anti-paramylon antibody titer 4) questionnaire survey about physical condition, defecation behavior, eating behavior, exercise behavior

Countries

Japan

Contacts

Public ContactMachiko Nishioka

KOBELCO ECO-SOLUTIONS CO., LTD. Technical Develop Center

nishioka.machiko@kobelco.com078-992-6957

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026